PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound
Ling Cen(Nationwide Children's Hospital), Jiayuh Lin(University of Maryland, Baltimore)
Cited by 59
Related Papers
Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
|Cancer Research|2010|233
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells
|Neuro-Oncology|2012|187
Stat3 activation in human endometrial and cervical cancers
|British Journal of Cancer|2007|164
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer
|British Journal of Cancer|2005|150
LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model
|British Journal of Cancer|2009|93